Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry).

Authors :: Gargiulo P
Marzano F
Crisci M
Marcucci R
Bruzzese D
Maloberti A
Sarullo FM
Galasso G
Indolfi C
Musumeci G
Corleto A
Calabrò P
Carugo S
Casu G
Picciolo A
Ciccone MM
Bilato C
Polimeni A
Giallauria F
Catalano A
De Luca L
Niccoli G
Venturini E
Pepe M
Montisci R
Brunetti ND
Patti G
Porto I
Margonato A
Floresta M
Muscoli S
Cameli M
Andò G
Di Lorenzo E
Berteotti M
Giannattasio C
Sarullo S
Formisano C
Di Costanzo A
Delnevo F
Varbella F
Cesaro A
Franzese M
Mancusi C
Fontanarosa S
Di Santo M
Cotticelli C
Perrone Filardi F
Paolillo S
Esposito G
Corsini A
Perrone Filardi P
Source :: Journal of the American College of Cardiology [J Am Coll Cardiol] 2024 Dec 04. Date of Electronic Publication: 2024 Dec 04.
Publication Year :: 2024
Publisher :: Ahead of Print
Abstract: Competing Interests: Funding Support and Author Disclosures Dr Corsini has received consulting fees and lecture fees from Algorithm, Amarin, Amgen, DOC, Fidia, Novartis, Merck Sharp & Dohme, Recordati Spa, Sanofi, Servier, and Viatris; and has received grant support from Daiichi-Sankyo. The other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Full Text Access

Tools